EPISODE · Feb 10, 2026 · 36 MIN
Scaling a SaaS Selling to Skeptical Scientists with Mike Klein, CEO of Genomenon
from SaaS Scaling Secrets · host Dan Balcauski
Dan Balcauski speaks with Mike Klein, CEO of Genomenon, a genomics intelligence company that combines AI, data, and real-world evidence to create a comprehensive knowledge base for precision therapeutics. Mike discusses his journey in scaling Genomenon, the challenges of selling to scientifically-minded customers, and the strategic shift to a freemium model that led to significant adoption. He highlights the complexities of transitioning from a small to a large team, the importance of delegation, and leveraging board relationships for company growth. Mike also shares insights on maintaining company culture, learning continually, and the invaluable lessons from his mentor. 01:19 Meet Mike Klein, CEO of Genomenon03:48 Navigating the Genomics Market10:19 Freemium Model Success18:20 Delegation and Leadership Insights26:22 Board Relationships and GovernanceGuest LinksGenomenon.com
What this episode covers
Dan Balcauski speaks with Mike Klein, CEO of Genomenon, a genomics intelligence company that combines AI, data, and real-world evidence to create a comprehensive knowledge base for precision therapeutics. Mike discusses his journey in scaling Genomenon, the challenges of selling to scientifically-minded customers, and the strategic shift to a freemium model that led to significant adoption. He highlights the complexities of transitioning from a small to a large team, the importance of delegat...
NOW PLAYING
Scaling a SaaS Selling to Skeptical Scientists with Mike Klein, CEO of Genomenon
No transcript for this episode yet